Phibro Animal Health Corporation Company Profile (NASDAQ:PAHC)

About Phibro Animal Health Corporation

Phibro Animal Health Corporation logoPhibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Specialized Health Services
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PAHC
  • CUSIP:
Key Metrics:
  • Previous Close: $29.15
  • 50 Day Moving Average: $28.48
  • 200 Day Moving Average: $26.66
  • 52-Week Range: $16.80 - $30.85
  • Trailing P/E Ratio: 19.56
  • Foreward P/E Ratio: 19.18
  • P/E Growth: 4.52
  • Market Cap: $1.15B
  • Outstanding Shares: 39,417,000
  • Beta: 1.34
Profitability:
  • Net Margins: 7.90%
  • Return on Equity: 63.70%
  • Return on Assets: 10.21%
Debt:
  • Debt-to-Equity Ratio: 2.89%
  • Current Ratio: 3.28%
  • Quick Ratio: 1.74%
Additional Links:
Companies Related to Phibro Animal Health Corporation:

Analyst Ratings

Consensus Ratings for Phibro Animal Health Corporation (NASDAQ:PAHC) (?)
Ratings Breakdown: 2 Sell Ratings, 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.17)
Consensus Price Target: $27.40 (6.00% downside)

Analysts' Ratings History for Phibro Animal Health Corporation (NASDAQ:PAHC)
Show:
DateFirmActionRatingPrice TargetDetails
2/8/2017Piper Jaffray CompaniesBoost Price TargetOverweight$32.00 -> $34.00View Rating Details
11/11/2016MacquarieDowngradeNeutral -> Underperform$21.00View Rating Details
11/10/2016GabelliDowngradeBuy -> HoldView Rating Details
9/12/2016GuggenheimSet Price TargetBuy$26.00 -> $30.00View Rating Details
9/4/2016Morgan StanleySet Price TargetSell$23.00View Rating Details
8/30/2016Credit Suisse GroupReiterated RatingBuy$29.00View Rating Details
1/15/2016Barclays PLCDowngradeOverweight -> Underweight$36.00 -> $31.00View Rating Details
5/14/2015Cantor FitzgeraldReiterated RatingBuy$36.00 -> $42.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Phibro Animal Health Corporation (NASDAQ:PAHC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017        
2/6/2017Q217$0.35$0.39$194.16 million$192.00 millionViewListenView Earnings Details
11/9/2016Q1 2017$0.34$0.36$188.85 million$188.00 millionViewListenView Earnings Details
8/29/2016Q416$0.38$0.40$189.20 millionViewN/AView Earnings Details
5/9/2016Q316$0.43$0.38$197.24 million$183.00 millionViewN/AView Earnings Details
2/9/2016Q216$0.41$0.39$198.27 million$191.80 millionViewN/AView Earnings Details
11/9/2015Q1$0.41$0.44$192.28 million$187.10 millionViewN/AView Earnings Details
9/9/2015Q415$0.38$0.44$185.00 millionViewN/AView Earnings Details
5/11/2015Q315$0.36$0.41$187.80 million$187.50 millionViewN/AView Earnings Details
2/10/2015Q215$0.36$0.35$181.52 million$188.70 millionViewN/AView Earnings Details
11/11/2014Q115$0.35$0.51$174.90 million$187.50 millionViewN/AView Earnings Details
9/16/2014Q414$0.27$0.22$184.00 millionViewN/AView Earnings Details
5/13/2014Q314$0.14$0.21$162.70 million$173.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Phibro Animal Health Corporation (NASDAQ:PAHC)
Current Year EPS Consensus Estimate: $1.43 EPS
Next Year EPS Consensus Estimate: $1.52 EPS

Dividends

Current Dividend Information for Phibro Animal Health Corporation (NASDAQ:PAHC)
Annual Dividend:$0.40
Dividend Yield:1.37%
Payout Ratio:26.85% (Based on Trailing 12 Months of Earnings)
27.97% (Based on Current Year Consensus EPS Estimate)
26.32% (Based on Next Year Consensus EPS Estimate)

Dividend History for Phibro Animal Health Corporation (NASDAQ:PAHC)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/7/2017quarterly$0.101.37%2/27/20173/1/20173/22/2017
11/8/2016quarterly$0.101.51%11/28/201611/30/201612/21/2016
7/26/2016quarterly$0.101.95%9/2/20169/7/20169/28/2016
5/10/2016quarterly$0.102.17%5/27/20166/1/20166/22/2016
2/9/2016quarterly$0.101.18%2/29/20163/2/20163/23/2016
11/10/2015quarterly$0.101.26%11/30/201512/2/201512/23/2015
7/28/2015quarterly$0.101.08%8/31/20159/2/20159/23/2015
5/12/2015quarterly$0.101.09%6/1/20156/3/20156/24/2015
2/10/2015quarterly$0.101.43%3/2/20153/4/20153/25/2015
11/10/2014quarterly$0.101.43%12/1/201412/3/201412/23/2014
7/28/2014quarterly$0.108/29/20149/3/20149/24/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Phibro Animal Health Corporation (NASDAQ:PAHC)
Insider Ownership Percentage: 48.09%
Institutional Ownership Percentage: 47.35%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/16/2017Daniel A WelchSVPSell5,000$29.55$147,750.00View SEC Filing  
2/16/2017Larry Lee MillerCOOSell4,588$30.00$137,640.00View SEC Filing  
2/15/2017Gerald K CarlsonDirectorSell12,000$29.77$357,240.00View SEC Filing  
2/13/2017Larry Lee MillerCOOSell97,229$30.37$2,952,844.73View SEC Filing  
1/4/2017Thomas G DaggerSVPSell207$30.00$6,210.00View SEC Filing  
1/3/2017Larry Lee MillerCOOSell187$30.00$5,610.00View SEC Filing  
12/20/2016Larry Lee MillerCOOSell1,540$30.04$46,261.60View SEC Filing  
12/20/2016Thomas G DaggerSVPSell1,700$30.03$51,051.00View SEC Filing  
12/19/2016Larry Lee MillerCOOSell252$30.00$7,560.00View SEC Filing  
12/19/2016Thomas G DaggerSVPSell200$30.01$6,002.00View SEC Filing  
5/19/2016E Thomas CorcoranDirectorBuy5,000$18.14$90,700.00View SEC Filing  
4/1/2016Gerald K CarlsonCOOSell8,000$27.02$216,160.00View SEC Filing  
2/19/2016Gerald K CarlsonCOOSell8,000$28.09$224,720.00View SEC Filing  
2/17/2016Bfi Co., LlcMajor ShareholderSell2,175$30.01$65,271.75View SEC Filing  
2/10/2016Bfi Co., Llcmajor shareholderSell3,400$30.78$104,652.00View SEC Filing  
2/3/2016Bfi Co., Llcmajor shareholderSell4,000$33.26$133,040.00View SEC Filing  
2/3/2016Jack BendheimCEOSell12,000$33.39$400,680.00View SEC Filing  
2/2/2016Bfi Co., Llcmajor shareholderSell4,000$33.44$133,760.00View SEC Filing  
2/1/2016Bfi Co., Llcmajor shareholderSell4,000$33.46$133,840.00View SEC Filing  
2/1/2016Larry Lee MillerPresidentSell60,000$33.58$2,014,800.00View SEC Filing  
1/29/2016Jack BendheimCEOSell39,944$32.10$1,282,202.40View SEC Filing  
1/26/2016Daniel A. WelchSVPSell3,000$32.05$96,150.00View SEC Filing  
1/26/2016Gerald K. CarlsonCOOSell12,923$32.13$415,215.99View SEC Filing  
1/22/2016Larry Lee MillerPresidentSell51,225$30.07$1,540,335.75View SEC Filing  
1/20/2016Gerald K. CarlsonCOOSell8,000$29.27$234,160.00View SEC Filing  
1/8/2016Larry Lee MillerPresidentSell4,303$30.03$129,219.09View SEC Filing  
1/6/2016Bfi Co., Llcmajor shareholderSell3,005$29.93$89,939.65View SEC Filing  
1/6/2016Jack BendheimCEOSell8,056$30.01$241,760.56View SEC Filing  
1/6/2016Larry Lee MillerPresidentSell4,472$30.10$134,607.20View SEC Filing  
1/5/2016Bfi Co., Llcmajor shareholderSell4,851$30.07$145,869.57View SEC Filing  
1/4/2016Bfi Co., Llcmajor shareholderSell200$29.92$5,984.00View SEC Filing  
12/30/2015Bfi Co., Llcmajor shareholderSell4,000$30.63$122,520.00View SEC Filing  
12/30/2015Jack BendheimCEOSell12,000$30.49$365,880.00View SEC Filing  
12/29/2015Bfi Co., Llcmajor shareholderSell4,000$30.49$121,960.00View SEC Filing  
12/28/2015Bfi Co., Llcmajor shareholderSell4,000$30.34$121,360.00View SEC Filing  
12/23/2015Gerald K. CarlsonCOOSell2,006$32.03$64,252.18View SEC Filing  
12/22/2015Gerald K. CarlsonCOOSell1,071$32.02$34,293.42View SEC Filing  
12/21/2015Gerald K. CarlsonCOOSell8,000$31.13$249,040.00View SEC Filing  
12/18/2015Jack BendheimCEOSell12,000$31.83$381,960.00View SEC Filing  
12/15/2015Larry Lee MillerinsiderSell36,090$31.00$1,118,790.00View SEC Filing  
12/14/2015Larry Lee MillerinsiderSell23,910$30.74$734,993.40View SEC Filing  
12/11/2015Jack BendheimCEOSell12,000$31.58$378,960.00View SEC Filing  
12/3/2015Jack BendheimCEOSell12,000$32.63$391,560.00View SEC Filing  
11/24/2015Gerald K. CarlsonCOOSell16,000$32.08$513,280.00View SEC Filing  
11/24/2015Thomas G. DaggerSVPSell4,000$32.87$131,480.00View SEC Filing  
11/18/2015Bfi Co., Llcmajor shareholderSell4,000$31.68$126,720.00View SEC Filing  
11/18/2015Jack BendheimCEOSell12,000$31.63$379,560.00View SEC Filing  
11/17/2015Bfi Co., Llcmajor shareholderSell4,000$31.71$126,840.00View SEC Filing  
11/16/2015Bfi Co., Llcmajor shareholderSell4,000$31.50$126,000.00View SEC Filing  
11/12/2015Bfi Co., Llcmajor shareholderSell12,000$32.21$386,520.00View SEC Filing  
11/5/2015Jack BendheimCEOSell12,000$33.11$397,320.00View SEC Filing  
10/30/2015Jack BendheimCEOSell12,000$33.21$398,520.00View SEC Filing  
10/26/2015Gerald K. CarlsonCOOSell7,900$32.15$253,985.00View SEC Filing  
10/26/2015Jack BendheimCEOSell12,000$31.73$380,760.00View SEC Filing  
10/21/2015Gerald K. CarlsonCOOSell8,100$32.40$262,440.00View SEC Filing  
10/16/2015Daniel A. WelchSVPSell3,000$32.93$98,790.00View SEC Filing  
10/16/2015Jack BendheimCEOSell12,000$32.10$385,200.00View SEC Filing  
10/9/2015Jack BendheimCEOSell12,000$30.64$367,680.00View SEC Filing  
10/1/2015Jack BendheimCEOSell12,000$31.44$377,280.00View SEC Filing  
9/25/2015Jack BendheimCEOSell10,000$33.95$339,500.00View SEC Filing  
9/23/2015Thomas G. DaggerSVPSell4,000$34.76$139,040.00View SEC Filing  
9/22/2015Gerald K. CarlsonCOOSell8,000$34.97$279,760.00View SEC Filing  
9/21/2015Gerald K. CarlsonCOOSell8,000$35.99$287,920.00View SEC Filing  
9/18/2015Jack BendheimCEOSell18,000$35.90$646,200.00View SEC Filing  
9/16/2015Dean J. WarrasinsiderSell4,000$34.73$138,920.00View SEC Filing  
9/10/2015Jack BendheimCEOSell18,000$34.69$624,420.00View SEC Filing  
9/3/2015Bfi Co., Llcmajor shareholderSell16,900$35.08$592,852.00View SEC Filing  
9/3/2015Jack BendheimCEOSell1,100$35.10$38,610.00View SEC Filing  
8/28/2015Jack BendheimCEOSell18,000$34.89$628,020.00View SEC Filing  
8/21/2015Gerald K. CarlsonCOOSell16,000$35.04$560,640.00View SEC Filing  
8/19/2015Bfi Co., LlcMajor ShareholderSell6,000$36.91$221,460.00View SEC Filing  
8/19/2015Jack BendheimCEOSell18,000$37.14$668,520.00View SEC Filing  
8/18/2015Bfi Co., LlcMajor ShareholderSell6,000$37.76$226,560.00View SEC Filing  
8/17/2015Bfi Co., LlcMajor ShareholderSell6,000$36.76$220,560.00View SEC Filing  
7/24/2015Jack BendheimCEOSell18,000$37.98$683,640.00View SEC Filing  
7/21/2015Gerald K CarlsonCOOSell8,000$37.97$303,760.00View SEC Filing  
7/20/2015Gerald K CarlsonCOOSell8,000$38.16$305,280.00View SEC Filing  
7/15/2015Bfi Co., LlcMajor ShareholderSell18,000$38.13$686,340.00View SEC Filing  
7/15/2015Jack BendheimCEOSell6,000$37.75$226,500.00View SEC Filing  
7/14/2015Jack BendheimCEOSell6,000$38.25$229,500.00View SEC Filing  
7/13/2015Jack BendheimCEOSell6,000$38.41$230,460.00View SEC Filing  
7/9/2015Jack BendheimCEOSell18,000$36.90$664,200.00View SEC Filing  
7/2/2015Bfi Co., LlcMajor ShareholderSell19,000$38.02$722,380.00View SEC Filing  
6/26/2015Jack BendheimCEOSell36,000$36.37$1,309,320.00View SEC Filing  
6/23/2015Gerald K CarlsonCOOSell16,000$36.56$584,960.00View SEC Filing  
6/22/2015Gerald K CarlsonCOOSell8,000$36.47$291,760.00View SEC Filing  
6/17/2015Bfi Co., LlcMajor ShareholderSell4,000$34.09$136,360.00View SEC Filing  
6/17/2015Jack BendheimCEOSell12,000$33.13$397,560.00View SEC Filing  
6/16/2015Bfi Co., LlcMajor ShareholderSell4,000$33.00$132,000.00View SEC Filing  
6/15/2015Bfi Co., LlcMajor ShareholderSell4,000$32.31$129,240.00View SEC Filing  
6/11/2015Jack BendheimCEOSell12,000$32.38$388,560.00View SEC Filing  
6/4/2015Jack BendheimCEOSell12,000$33.68$404,160.00View SEC Filing  
5/28/2015Bfi Co., LlcMajor ShareholderSell18,000$35.11$631,980.00View SEC Filing  
5/21/2015Gerald K CarlsonCOOSell16,000$35.62$569,920.00View SEC Filing  
5/19/2015Bfi Co., LlcMajor ShareholderSell18,000$36.73$661,140.00View SEC Filing  
5/18/2015Thomas G DaggerSVPSell4,000$36.48$145,920.00View SEC Filing  
12/19/2014Daniel A WelchSVPSell4,000$29.20$116,800.00View SEC Filing  
8/1/2014Bfi Co., LlcMajor ShareholderSell223,075$20.51$4,575,268.25View SEC Filing  
4/22/2014E Thomas CorcoranDirectorBuy5,000$16.70$83,500.00View SEC Filing  
4/16/2014Carol WrennDirectorBuy1,000$16.19$16,190.00View SEC Filing  
4/16/2014L.P. MayflowerMajor ShareholderSell6,323,867$13.99$88,470,899.33View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Phibro Animal Health Corporation (NASDAQ:PAHC)
DateHeadline
News IconStock Review: Level Check for Phibro Animal Health Corporation (NASDAQ:PAHC) - Searcy News (NASDAQ:PAHC)
searcysentinel.com - February 22 at 7:14 PM
News IconIs The Sell-Side Predicting That Phibro Animal Health Corporation (NASDAQ:PAHC) Will Move Higher? - Winfield Review (NASDAQ:PAHC)
winfieldreview.com - February 17 at 8:12 AM
News IconDirector of Phibro Animal Health Corporatio (NASDAQ:PAHC), Carlson Gerald K, sells 12,000 shares worth $357,240 (NASDAQ:PAHC)
empowerednews.net - February 16 at 11:42 PM
News IconDirector of Phibro Animal Health Corporatio (NASDAQ:PAHC), Carlson Gerald K, sells 12,000 shares worth $357,240 (NASDAQ:PAHC)
empowerednews.net - February 16 at 11:42 PM
News IconStock Update: Focusing on Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) - Midway Monitor (NASDAQ:PAHC)
midwaymonitor.com - February 15 at 4:06 AM
News IconSVP, Gen Counsel and Corp Secr of Phibro Animal Health Corporatio (NASDAQ:PAHC), Dagger Thomas G, sells 5,893 shares worth $178,381 (NASDAQ:PAHC)
empowerednews.net - February 14 at 2:28 AM
seekingalpha.com logoPhibro Animal Health Corporation 2017 Q2 - Results - Earnings Call Slides (NASDAQ:PAHC)
seekingalpha.com - February 9 at 8:31 PM
capitalcube.com logoPhibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q2, 2017 By the Numbers : February 9, 2017 (NASDAQ:PAHC)
www.capitalcube.com - February 9 at 8:31 PM
biz.yahoo.com logoPHIBRO ANIMAL HEALTH CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:PAHC)
us.rd.yahoo.com - February 8 at 8:04 PM
biz.yahoo.com logoPHIBRO ANIMAL HEALTH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial (NASDAQ:PAHC)
us.rd.yahoo.com - February 8 at 8:04 PM
capitalcube.com logoPhibro Animal Health Corp. breached its 50 day moving average in a Bullish Manner : PAHC-US : February 8, 2017 (NASDAQ:PAHC)
us.rd.yahoo.com - February 8 at 8:04 PM
News IconPhibro Animal Health (NASDAQ:PAHC) 2Q17 earnings; Beats Street View (NASDAQ:PAHC)
stockmarketdaily.co - February 7 at 9:06 AM
finance.yahoo.com logoPhirbo Animal (PAHC) Tops Q2 Earnings, Reaffirms FY17 View (NASDAQ:PAHC)
finance.yahoo.com - February 7 at 9:06 AM
us.rd.yahoo.com logoPhibro Animal Health Corporation Reports Second Quarter (NASDAQ:PAHC)
us.rd.yahoo.com - February 7 at 12:11 AM
us.rd.yahoo.com logo4:18 pm Philbro Animal Health beats by $0.04, reports revs in-line; reaffirms FY17 EPS guidance, revs guidance (NASDAQ:PAHC)
us.rd.yahoo.com - February 7 at 12:11 AM
streetinsider.com logoPhibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.4% Yield (NASDAQ:PAHC)
www.streetinsider.com - February 6 at 7:10 PM
reuters.com logoBRIEF-Phibro Animal Health Corporation Q2 diluted earnings per share $0.34 (NASDAQ:PAHC)
www.reuters.com - February 6 at 7:10 PM
News IconPhibro Animal Health Corporation (PAHC): Should the future outlook worry you? (NASDAQ:PAHC)
simplywall.st - February 6 at 7:10 PM
marketexclusive.com logoPhibro Animal Health Corporation (NASDAQ:PAHC) Files An 8-K Results of Operations and Financial Condition (NASDAQ:PAHC)
marketexclusive.com - February 6 at 7:10 PM
sg.finance.yahoo.com logoPhibro posts 2Q profit (NASDAQ:PAHC)
sg.finance.yahoo.com - February 6 at 7:10 PM
feeds.benzinga.com logoPhibro Animal Health Corporation Declares Quarterly Dividend (NASDAQ:PAHC)
feeds.benzinga.com - February 6 at 4:52 PM
biz.yahoo.com logoQ2 2017 Phibro Animal Health Corp Earnings Release - After Market Close (NASDAQ:PAHC)
biz.yahoo.com - February 6 at 9:15 AM
News IconPhibro Animal Health (NASDAQ:PAHC) 2Q17 earnings preview (NASDAQ:PAHC)
stockmarketdaily.co - February 5 at 11:55 PM
News IconPhibro Expands Production Capacity of Animate Anionic Mineral Supplement to Meet Growing Demand (NASDAQ:PAHC)
www.dairyherd.com - January 24 at 7:51 PM
News IconPhibro adds big manufacuring plant south of Quincy (NASDAQ:PAHC)
www.whig.com - January 21 at 12:57 AM
capitalcube.com logoPhibro Animal Health Corp. – Value Analysis (NASDAQ:PAHC) : January 18, 2017 (NASDAQ:PAHC)
www.capitalcube.com - January 18 at 7:43 PM
News IconPhibro opens new plant in Quincy (NASDAQ:PAHC)
khqa.com - January 18 at 8:42 AM
capitalcube.com logoETFs with exposure to Phibro Animal Health Corp. : January 17, 2017 (NASDAQ:PAHC)
www.capitalcube.com - January 17 at 7:30 PM
News IconPhibro Offers Research Index for Supporting Dairy Cow Immune Function (NASDAQ:PAHC)
www.dairyherd.com - January 17 at 11:13 AM
capitalcube.com logoPhibro Animal Health Corp. breached its 50 day moving average in a Bearish Manner : PAHC-US : January 13, 2017 (NASDAQ:PAHC)
www.capitalcube.com - January 13 at 8:10 AM
News IconPhibro Animal Health Corp PAHC Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:PAHC)
www.bioportfolio.com - January 8 at 11:51 PM
publicnow.com logoPhibro Animal Health Corporation to Host Webcast and Conference Call on December 2016 Quarterly Financial Results (NASDAQ:PAHC)
www.publicnow.com - January 5 at 11:51 PM
marketexclusive.com logoPhibro Animal Health Corporation (NASDAQ:PAHC) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:PAHC)
marketexclusive.com - December 24 at 12:19 AM
biz.yahoo.com logoPHIBRO ANIMAL HEALTH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financ (NASDAQ:PAHC)
biz.yahoo.com - December 23 at 7:17 PM
marketexclusive.com logoAnalyst Activity – Piper Jaffray Cos. Initiates Coverage On Phibro Animal Health Corp. (NASDAQ:PAHC) With a Overweight (NASDAQ:PAHC)
marketexclusive.com - December 17 at 12:54 AM
streetinsider.com logoPiper Jaffray Starts Phibro Animal Health Corp. (PAHC) at Overweight (NASDAQ:PAHC)
www.streetinsider.com - December 17 at 12:54 AM
us.rd.yahoo.com logoCoverage initiated on Philbro Animal Health by Piper Jaffray (NASDAQ:PAHC)
us.rd.yahoo.com - December 15 at 8:07 PM
News IconPhibro Animal Health Corp PAHC Financial and Strategic SWOT Analysis Review Prices from USD $125 (NASDAQ:PAHC)
www.bioportfolio.com - December 6 at 6:49 PM
capitalcube.com logoPhibro Animal Health Corp. breached its 50 day moving average in a Bearish Manner : PAHC-US : December 5, 2016 (NASDAQ:PAHC)
www.capitalcube.com - December 5 at 9:48 AM
capitalcube.com logoPhibro Animal Health Corp. : PAHC-US: Dividend Analysis : November 30th, 2016 (record date) : By the numbers : December 1, 2016 (NASDAQ:PAHC)
www.capitalcube.com - December 1 at 7:00 PM
capitalcube.com logoETFs with exposure to Phibro Animal Health Corp. : November 30, 2016 (NASDAQ:PAHC)
www.capitalcube.com - November 30 at 7:17 PM
capitalcube.com logoPhibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q1, 2017 By the Numbers : November 22, 2016 (NASDAQ:PAHC)
www.capitalcube.com - November 22 at 11:02 AM
News IconPhibro Animal Health Corporation PAHC Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:PAHC)
www.bioportfolio.com - November 20 at 10:51 AM
finance.yahoo.com logoPHIBRO ANIMAL HEALTH CORP Financials (NASDAQ:PAHC)
finance.yahoo.com - November 17 at 6:25 PM
seekingalpha.com logoPhibro's (PAHC) CEO Jack Bendheim on Q1 2017 Results - Earnings Call Transcript (NASDAQ:PAHC)
seekingalpha.com - November 11 at 9:30 AM
finance.yahoo.com logoEdited Transcript of PAHC earnings conference call or presentation 10-Nov-16 2:00pm GMT (NASDAQ:PAHC)
finance.yahoo.com - November 11 at 9:30 AM
finance.yahoo.com logoPhibro Animal Health (PAHC) Beats Q1 Earnings, Margins Up (NASDAQ:PAHC)
finance.yahoo.com - November 11 at 9:30 AM
sg.finance.yahoo.com logoPhibro posts 1Q profit (NASDAQ:PAHC)
sg.finance.yahoo.com - November 10 at 9:49 AM
finance.yahoo.com logoPhilbro Animal Health downgraded by Gabelli & Co (NASDAQ:PAHC)
finance.yahoo.com - November 10 at 9:49 AM
reuters.com logoBRIEF-Phibro Animal Health Q1 reports Q1 results (NASDAQ:PAHC)
www.reuters.com - November 9 at 6:40 PM

Social

What is Phibro Animal Health Corporation's stock symbol?

Phibro Animal Health Corporation trades on the NASDAQ under the ticker symbol "PAHC."

How often does Phibro Animal Health Corporation pay dividends? What is the dividend yield for Phibro Animal Health Corporation?

Phibro Animal Health Corporation declared a quarterly dividend on Tuesday, February 7th. Shareholders of record on Wednesday, March 1st will be given a dividend of $0.10 per share on Wednesday, March 22nd. This represents a $0.40 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date is Monday, February 27th.

Where is Phibro Animal Health Corporation's stock going? Where will Phibro Animal Health Corporation's stock price be in 2017?

6 brokerages have issued 12-month price objectives for Phibro Animal Health Corporation's shares. Their predictions range from $21.00 to $34.00. On average, they expect Phibro Animal Health Corporation's stock price to reach $27.40 in the next twelve months.

When will Phibro Animal Health Corporation announce their earnings?

Phibro Animal Health Corporation is scheduled to release their next quarterly earnings announcement on Monday, May, 8th 2017.

What are analysts saying about Phibro Animal Health Corporation stock?

Here are some recent quotes from research analysts about Phibro Animal Health Corporation stock:

  • Piper Jaffray Companies analysts commented, "We continue to favor shares of PAHC as a top small cap idea in our ag space, where we see potential for upward revisions to guidance in 2H17 following the 2Q earnings beat and management reaffirming guidance. Positively, the Animal Health segment grew in the December-ending quarter despite ongoing headwinds in MFAs, supporting our thesis around the resilience of the animal health industry. We are lifting our FY17 EPS estimate to $1.45 at the top of the guidance range and we see potential earnings upside in 2H17 from growth outside of MFAs and in other geographies like Brazil. We see multiple expansion opportunity with some of the MFA overhang on the stock removed after the resilient 2Q results and our price target moves to $34 based on 21X FY18E EPS of $1.60. We reiterate our Overweight rating." (2/8/2017)
  • According to Zacks Investment Research, "Phibro ended the fourth quarter of 2016 on an unsatisfactory note with deteriorating earnings on a year-over-year basis. However, the company successfully managed to beat the Zacks Consensus Estimate in both counts posting a top-line improvement, courtesy Animal Health and Performance Products segments. Meanwhile, Phibro sells the bulk of its products to a diverse number and variety of customers. Significant consolidation of the company’s customers might increase the product pricing pressures challenging Phibro’s business. Additionally, currency headwinds, sluggish macro economic conditions and a tough competitive scenario also continue to hurt growth." (11/2/2016)

Who owns Phibro Animal Health Corporation stock?

Phibro Animal Health Corporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include RidgeWorth Capital Management LLC (3.09%), Foresters Investment Management Company Inc. (3.03%), Thornburg Investment Management Inc. (2.54%), Denver Investment Advisors LLC (1.88%), State Street Corp (1.17%) and FMR LLC (1.12%). Company insiders that own Phibro Animal Health Corporation stock include Bfi Co, Llc, Daniel A Welch, Dean J Warras, E Thomas Corcoran, Gerald K Carlson, Jack Bendheim, Larry Lee Miller and Thomas G Dagger.

Who sold Phibro Animal Health Corporation stock? Who is selling Phibro Animal Health Corporation stock?

Phibro Animal Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc., FMR LLC, Hotchkis & Wiley Capital Management LLC, Denver Investment Advisors LLC, Janus Capital Management LLC, GSA Capital Partners LLP, AQR Capital Management LLC and RidgeWorth Capital Management LLC. Company insiders that have sold Phibro Animal Health Corporation stock in the last year include Daniel A Welch, Gerald K Carlson, Larry Lee Miller and Thomas G Dagger.

Who bought Phibro Animal Health Corporation stock? Who is buying Phibro Animal Health Corporation stock?

Phibro Animal Health Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Trexquant Investment LP, Paradigm Asset Management Co. LLC, Dimensional Fund Advisors LP, Menta Capital LLC, Renaissance Technologies LLC, Tudor Investment Corp Et Al, Two Sigma Investments LP and Foresters Investment Management Company Inc..

How do I buy Phibro Animal Health Corporation stock?

Shares of Phibro Animal Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Phibro Animal Health Corporation stock cost?

One share of Phibro Animal Health Corporation stock can currently be purchased for approximately $29.15.

Phibro Animal Health Corporation (NASDAQ:PAHC) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Earnings History Chart

Earnings by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Dividend History Chart

Dividend Payments by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Last Updated on 2/22/2017 by MarketBeat.com Staff